JL

Joe Lussa

.

๐Ÿ“ United States๐Ÿ”„ Updated September 2026๐Ÿ’ผ 2 investments๐Ÿ“… 4 years investing๐Ÿ—“ Last invested Dec 2023
Operator-angel๐ŸŒ United States
2
Total investments
2
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

2 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2023
Golfs premium betting app. Compete against your friends for real money and get paid instantly.
Investor
Jun 2022
Exom BioPharma has isolated a novel exosome from FDA approved food source (named as Q5 EXOSOMES) which has several technological advantages over stem cells and bovine milk derived exosomes. Exom BioPharma offers high quality research kits for exosome isolation and analysis, manufacturing highly purified exosomes from various cell lines, and animal and plant sources for research and preclinical (drug delivery) applications. Our company is also actively engaged in targeted exosome delivery research using our proprietary Q5 Exosome technology and identifying biomarkers for the early diagnosis of Pancreatic & Head and Neck Cancer and cardiovascular disease. Our company is also working towards procuring patient related biospecimen (blood, urine, saliva, CSF) and isolating cfDNA and exosomes for biomarker discovery. We are looking for R&D collaborations with research institutions and pharmaceutical companies for our Q5 Exosomes.
Experience ยท 5 entries
All (5)
Investments (2)
Founder (1)
2023
Investor
Dec 2023
Golfs premium betting app. Compete against your friends for real money and get paid instantly.
Co-Founder
Nov 2023
No Ecosystem Was Harmed In The Creation Of This Water
Partner
Jun 2023
As a business owner, your focus should be growth, not grappling with merchant services complexities, payment processing variations, or PCI compliance hurdles. With over 10 years of experience, we understand the frustration of navigating credit card payment complexities, security concerns, and budget constraints. The need for impeccable security, streamlined operations, and cost-effectiveness is paramount. Enter Electrify Payments, where we prioritize your online financial safety. We deliver top-tier Credit Card processing, that fuels revenue growth while safeguarding your clientele. What you REALLY need: ๐Ÿ’ธ Seamless Payments ๐Ÿ“ˆ Increased Efficiency ๐Ÿ”’ Impenetrable Data Security At our core is your security. We cultivate smoother, safer payment landscapes, empowering confident transactions. While you get to concentrate on your strengths - running a successful business, free from payment hassles. From small enterprises to corporate giants, expect unwavering support, and game-changing payment processing merchant services. Committed to exceptional customer service, our service delivers trust and confidence. Rest easy by meeting your payment processing needs with precision, efficiency, dependability, and safety. What We Can Help With: ๐Ÿ”’ Credit Card Processing Advancements ๐Ÿ”ง Merchant Services Assistance ๐Ÿ“Š Payment Processing Strategy and Solutions ๐Ÿ” PCI Compliance ๐Ÿ”’ PCIDSS Assistance ๐Ÿ”’ Point To Point Encryption ๐Ÿ”’ P2PE Expertise ๐Ÿ’ผ Interchange Optimization ๐Ÿ” Data Breach Prevention ๐Ÿ’ผ Payment Advisory Assistance We Serve: ๐ŸŽญ Entertainment Industry ๐Ÿ” Food and Beverage Industry ๐ŸŽ“ Educational Industry โ›ฝ Gas Industry ๐Ÿ›๏ธ Convenience Industry Blending cutting-edge technology and expert experience, we can help you with secure, seamless, and swift payment processing solutions. Embark on this journey with us, as we strengthen your business and propel you to that next breakthrough.
2022
Investor
Jun 2022
Exom BioPharma has isolated a novel exosome from FDA approved food source (named as Q5 EXOSOMES) which has several technological advantages over stem cells and bovine milk derived exosomes. Exom BioPharma offers high quality research kits for exosome isolation and analysis, manufacturing highly purified exosomes from various cell lines, and animal and plant sources for research and preclinical (drug delivery) applications. Our company is also actively engaged in targeted exosome delivery research using our proprietary Q5 Exosome technology and identifying biomarkers for the early diagnosis of Pancreatic & Head and Neck Cancer and cardiovascular disease. Our company is also working towards procuring patient related biospecimen (blood, urine, saliva, CSF) and isolating cfDNA and exosomes for biomarker discovery. We are looking for R&D collaborations with research institutions and pharmaceutical companies for our Q5 Exosomes.
2020
Partner
Feb 2020
Empire Rx is a VAWD accredited wholesale distributor located in Airmont, NY. Looking for new reps with books of business Email: jlussa@empirerx.com We have Pharmaceutical Sales Rep Opportunities. Pharmaceutical Wholesale Products - Selling to pharmacies.